Cargando…
Memantine as treatment for compulsivity in child and adolescent psychiatry: Descriptive findings from an incompleted randomized, double-blind, placebo-controlled trial
BACKGROUND: Autism spectrum disorder (ASD) and obsessive-compulsive disorder (OCD) are mental disorders with a considerable overlap in terms of their defining symptoms. The glutamatergic agent memantine appears to be a promising candidate for the treatment of ASD and OCD in children and adolescents....
Autores principales: | Niemeyer, Larissa, Mechler, Konstantin, Dittmann, Ralf W., Banaschewski, Tobias, Buitelaar, Jan, Durston, Sarah, Häge, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450066/ https://www.ncbi.nlm.nih.gov/pubmed/36092975 http://dx.doi.org/10.1016/j.conctc.2022.100982 |
Ejemplares similares
-
“Include me if you can”—reasons for low enrollment of pediatric patients in a psychopharmacological trial
por: Niemeyer, Larissa, et al.
Publicado: (2021) -
Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) – study protocol for a randomised controlled trial
por: Häge, Alexander, et al.
Publicado: (2016) -
Memantine for Refractory Obsessive-Compulsive Disorder: Protocol for a Pragmatic, Double-blind, Randomized, Parallel-Group, Placebo-Controlled, Monocenter Trial
por: Maraone, Annalisa, et al.
Publicado: (2023) -
Memantine treatment does not affect compulsive behavior or frontostriatal connectivity in an adolescent rat model for quinpirole-induced compulsive checking behavior
por: Straathof, Milou, et al.
Publicado: (2022) -
Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial
por: Askari, Sanaz, et al.
Publicado: (2022)